S100 proteins in IgA vasculitis and other systemic vasculitides – from pathogenic mechanisms to clinical biomarkers: a systematic review

Key Takeaways for GI Nurses

• S100 proteins are emerging as potential biomarkers for IgA vasculitis and other systemic vasculitides that commonly present with gastrointestinal manifestations
• Understanding S100 protein involvement in vasculitic processes may help nurses recognize early GI symptoms and complications in patients with systemic inflammatory conditions
• This research supports the development of more targeted diagnostic approaches that could streamline patient assessment and monitoring protocols in endoscopy units
• Knowledge of S100 proteins as inflammatory markers enhances nurses' ability to correlate laboratory findings with clinical presentations during patient care

Clinical Relevance

For gastroenterology and endoscopy nurses, this systematic review highlights the critical intersection between systemic vasculitides and gastrointestinal manifestations. IgA vasculitis, formerly known as Henoch-Schönlein purpura, frequently presents with abdominal pain, GI bleeding, and other digestive symptoms that bring patients to endoscopy units. Understanding the role of S100 proteins in the pathogenesis of these conditions provides nurses with deeper insight into the inflammatory processes underlying their patients' symptoms. This knowledge is particularly valuable when caring for pediatric and adult patients who may present with acute abdominal pain, bloody stools, or other GI complications associated with systemic vasculitis.

The potential clinical application of S100 proteins as biomarkers could significantly impact nursing practice in several ways. First, it may lead to more standardized protocols for monitoring patients with suspected or confirmed vasculitis undergoing endoscopic procedures. Nurses may need to become familiar with S100 protein testing as part of pre-procedural assessments, particularly when evaluating patients with unexplained GI symptoms and systemic inflammatory markers. Additionally, this research supports the importance of comprehensive patient histories and symptom assessment, as nurses often serve as the primary point of contact for identifying patterns that might suggest systemic involvement beyond isolated GI complaints.

From an operational perspective, advances in biomarker research like S100 proteins may influence unit protocols for patient preparation, risk stratification, and post-procedural monitoring. Nurses working in endoscopy units should stay informed about these developments as they may eventually translate into clinical practice guidelines that affect patient care workflows. This research also underscores the multidisciplinary nature of caring for patients with systemic conditions, reinforcing the need for effective communication between GI nurses and colleagues in rheumatology, nephrology, and other specialties when managing patients with vasculitic conditions.

Bottom Line

This systematic review on S100 proteins in IgA vasculitis and systemic vasculitides represents an important step toward better understanding the inflammatory mechanisms behind GI manifestations commonly seen in endoscopy practice. While S100 proteins are not yet part of routine clinical use, GI nurses should recognize their potential as future diagnostic tools and maintain awareness of how systemic inflammatory conditions can present with predominant gastrointestinal symptoms, ensuring comprehensive patient assessment and appropriate interdisciplinary collaboration in managing these complex cases.